Trials / Not Yet Recruiting
Not Yet RecruitingNCT07153705
OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (estimated)
- Sponsor
- Beihua Kong · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To study the performance of OCS products based on exosome detection technology in monitoring the recurrence of baseline CA125-negative ovarian cancer patients after initial treatment, and to explore reliable methods for monitoring the recurrence of baseline CA125-negative ovarian cancer patients after initial treatment.
Conditions
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2025-09-04
- Last updated
- 2025-09-04
Source: ClinicalTrials.gov record NCT07153705. Inclusion in this directory is not an endorsement.